Enfortumab vedotin and pembrolizumab with surgery significantly improve outcomes in cisplatin-ineligible MIBC patients, ...
The Gujarat Biotechnology University (GBU) has filed a provisional patent for supplement derived from Kinnow Mandarin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback